Changes in Director's Interest (Section 219 of CA 2016)
SUNZEN BIOTECH BERHAD |
Information Compiled By KLSE
Particulars of Director
Name | MR TEO YEK MING |
Descriptions(Class) | Ordinary Shares |
Details of changes
No | Date of change |
No of securities |
Type of transaction |
Nature of Interest |
28/05/2021
|
15,466,667
|
Others
|
Direct Interest
|
|
Name of registered holder | Teo Yek Ming | |||
Description of "Others" Type of Transaction | Allotment of Shares | |||
Consideration (if any) | RM0.165 per share | |||
28/05/2021
|
10,909,091
|
Others
|
Indirect Interest
|
|
Name of registered holder | RHB Capital Nominees (Tempatan) Sdn Bhd David Lai & Tan Services Sdn Bhd | |||
Description of "Others" Type of Transaction | Allotment of Shares | |||
Consideration (if any) | RM0.165 per share |
Circumstances by reason of which change has occurred | Allotment of Consideration Shares arising from the Acquisition of Finsource Solution Sdn. Bhd. by Sunzen Biotech Berhad |
Nature of interest | Direct and Indirect Interest |
Total no of securities after change |
|
Direct (units) | 84,180,417 |
Direct (%) | 14.700 |
Indirect/deemed interest (units) | 11,035,091 |
Indirect/deemed interest (%) | 1.930 |
Date of notice | 31/05/2021 |
Date notice received by Listed Issuer | 31/05/2021 |
Remarks : |
(1) Deemed interest by virtue of 126,000 shares held by parent. (2) Deemed interest by virtue of 10,909,091 shares held as security by David Lai & Tan Services Sdn Bhd pursuant to Section 8 of the Companies Act 2016. |
Announcement Info
Company Name | SUNZEN BIOTECH BERHAD |
Stock Name | SUNZEN |
Date Announced | 31 May 2021 |
Category | Changes in Director's Interest Pursuant to Section 219 of CA 2016 |
Reference Number | CS4-15032021-00044 |